ÂÜÀòÂÒÂ×

BM

Bob More

Chairman at Affinivax

Bob More is currently Managing Director at Alta Partners. Prior to Alta, Bob was at the Bill and Melinda Gates Foundation where he served as a Senior Advisor working on Program Related Investments and leading the foundation’s Global Health Venture Capital initiative. Previously, Bob was a Partner at Frazier Healthcare from 2008-2013 and a Partner at Domain Associates, having joined the firm in 1996 as a Kauffman Fellow and becoming a Partner in 2000. From 1997-1998, Bob served as the Chief Operating Officer of Small Molecule Therapeutics. Prior to attending business school, Bob held a Sales Position with Pharmacia and began his career in research at Somatogen, a start-up focused on a recombinant blood substitute. As a venture capitalist, Bob lead and oversaw investments in Biotechnology, Pharmaceuticals, Medical Devices, and Health Care IT. Bob was a Founding Board Member of the Kauffman Fellows Program and serves on several outside boards. He also serves as Chairman of One Revolution, an organization focused on challenging perspectives on disabilities. Bob received his BA from Middlebury College and an MBA from the Darden School of Business Administration at the University of Virginia.